Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (NQ: QNTM )

4.510 -0.030 (-0.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,151
Open 4.540
Bid (Size) 4.400 (5)
Ask (Size) 4.510 (1)
Prev. Close 4.540
Today's Range 4.330 - 4.622
52wk Range 2.700 - 18.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Phase 1 Trial for MS Treatment, Reports Positive Safety Results
Via Investor Brand Network
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
From Quantum BioPharma
Via GlobeNewswire

Performance

YTD
+10.54%
+10.54%
1 Month
-62.88%
-62.88%
3 Month
+7.13%
+7.13%
6 Month
+12.47%
+12.47%
1 Year
+5.62%
+5.62%

More News

Read More
Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
From Quantum BioPharma
Via GlobeNewswire
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages MZ Group for Investor Relations Strategy
Via Investor Brand Network
Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
From Quantum BioPharma
Via GlobeNewswire
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages Enterprise Canada, Empire Market Ventures for PR, Investor Awareness
Via Investor Brand Network
Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs
From Quantum BioPharma
Via GlobeNewswire
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge
Via Stocktwits
Which stocks are moving on Thursday?
Via Chartmill
Quantum BioPharma Shares Are Up Over 80%: What's Going On?
Via Benzinga
On Thursday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
Thursday's session: top gainers and losers
Via Chartmill
Thursday's session: gap up and gap down stocks
Via Chartmill
Dow Edges Higher; US Weekly Jobless Claims Increase
Via Benzinga
Topics Stocks
Exposures US Equities
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Licensee Celly Nutrition Pursues $10M Capital Raise and U.S. IPO
Via Investor Brand Network
Topics Initial Public Offering
Exposures Securities Market
Which stocks are moving before the opening bell on Thursday?
Via Chartmill
Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study
From Quantum BioPharma
Via GlobeNewswire
These stocks have an unusual volume in today's session
Via Chartmill
Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session.
Via Chartmill
Quantum BioPharma Shares Are Up Today: What's Going On?
Via Benzinga
Gold Moves Higher; Estée Lauder Shares Slide
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates
Via Benzinga
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Reports Positive Clinical Trial Results for unbuzzd™
Via Investor Brand Network
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.